Firefly Neuroscience, Inc.
AIFF
$2.66
$0.0110.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 428.00K | 139.00K | 108.00K | 74.00K | 64.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 428.00K | 139.00K | 108.00K | 74.00K | 64.00K |
| Cost of Revenue | 25.00K | -- | -- | -- | -- |
| Gross Profit | 403.00K | 139.00K | 108.00K | 74.00K | 64.00K |
| SG&A Expenses | 8.97M | 8.32M | 7.33M | 6.71M | 3.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.96M | 10.29M | 9.29M | 8.26M | 4.63M |
| Operating Income | -10.53M | -10.15M | -9.18M | -8.19M | -4.56M |
| Income Before Tax | -22.83M | -22.27M | -10.46M | -7.75M | -4.11M |
| Income Tax Expenses | 6.00K | 2.00K | 2.00K | 1.00K | 1.00K |
| Earnings from Continuing Operations | -22.84 | -22.27 | -10.46 | -7.75 | -4.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.84M | -22.27M | -10.46M | -7.75M | -4.11M |
| EBIT | -10.53M | -10.15M | -9.18M | -8.19M | -4.56M |
| EBITDA | -10.50M | -10.13M | -8.08M | -7.08M | -3.46M |
| EPS Basic | -2.93 | -3.03 | -1.50 | -1.36 | -0.93 |
| Normalized Basic EPS | -1.49 | -1.55 | -0.87 | -0.85 | -0.58 |
| EPS Diluted | -2.93 | -3.03 | -1.50 | -1.36 | -0.93 |
| Normalized Diluted EPS | -1.49 | -1.55 | -0.87 | -0.85 | -0.58 |
| Average Basic Shares Outstanding | 38.41M | 30.94M | 26.17M | 21.15M | 17.75M |
| Average Diluted Shares Outstanding | 38.41M | 30.94M | 26.17M | 21.15M | 17.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |